Searchable abstracts of presentations at key conferences in endocrinology

ea0016p186 | Diabetes and cardiovascular diseases | ECE2008

Comparison of patient's life quality between inhalated insulin therapy (Exubera) and conventional treatment

Tome Monica , Serrano Isabel , Morales Cristobal , Maraver Silvia , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Cuesta Carmen , Sendon Angel

Objectives: To evaluate satisfaction with treatment in diabetic patients under therapy with inhaled insulin (exubera).Material and methods: Thirty-seven diabetic patients were evaluated, 27DM1 (75%) and 9DM2 (25%) that initiated treatment with Insulin inhaled (EXUBERA) between August and October 2007. Twenty-five men (69.4%) and 11 women (30.56%), between 18 and 71 years old (38.4±16.4) and with a time of evolution of diabetes between 0 and 47 years...

ea0016p187 | Diabetes and cardiovascular diseases | ECE2008

Satisfaction degree and metabolic control in patients with glucose continuous monitoring system

Morales Cristobal , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Tome Monica , Maraver Silvia , Serrano Isabel , Cuesta Carmen , Sendon Angel

Objective: To study the improvement of metabolic control and patients satisfaction with glucose continuous monitoring systems (Guardian real time).Material and method: Fifteen DM1 patients studied (age: 33.8±13.40, years of evolution: 17.06±11.32) in intensive treatment (5 multidoses, 10 insulin pump) which were made one 4 days long blind monitoring Period 1 (blind period) with sensor CGMS Gold. Next another monitoring was made with a real time...

ea0016p188 | Diabetes and cardiovascular diseases | ECE2008

Metabolic control and quality of life in patients with DM1 and insulin pump therapy

Serrano Isabel , Morales Cristobal , Maraver Silvia , Martinez de Pinillos Guillermo , Garcia-Quiros Juan Manuel , Tome Monica , Cuesta Carmen , Sendon Angel

Objectives: To value the quality of life improvement and metabolic control in patients with DM1 in the 2 first years of treatment with insulin pump therapy.Material and methods: We studied 33 DM1 patients, 16 men (48.5%) and 17 women (51.5%), with average age of 34.2±12.2 and 16.3±10.21 years of disease. Pump indication was hypoglycemia in 10 (30.3%), badly metabolic control in 14 (42.4%), pregnancy in 5 (15.2%) and glycemic inestability in 4 (...

ea0016p189 | Diabetes and cardiovascular diseases | ECE2008

Utility of ambulatory blood pressure monitoring in diabetological consulting

Garcia-Quiros Juan Manuel , Serrano Isabel , Morales Cristobal , Martinez de Pinillos Guillermo , Maraver Silvia , Tome Monica , Cuesta Carmen , Sendon Angel

Objectives: To check possible advantages of ambulatory blood pressure monitoring (ABPM) in diagnosis and disease control respect to blood pressure conventional measurement ways.Also to study the circadian rhythm of each patient to detect higher cardiovascular risk situations.Material and methods: One hundred and nine patients were included in this study: 44% male, 56% female. ABPM were indicated in four different situations: hypert...

ea0016p383 | Neuroendocrinology | ECE2008

Is total and acylated ghrelin secretion after oral glucose modified by acromegaly?

Cordido Fernando , Penin Manuel , Isidro Luisa , Nemina Rosa , Sangiao Susana , Vidal Ovidio , Martinez Teresa , Jesus Garcia-Buela

Introduction: Although involved in feeding and weight homeostasis, stimulation of pituitary GH secretion is the best established action of stomach-produced hormone ghrelin. However, its role in regulation of GH secretion is not yet clear. Some evidence indicates that circulating concentrations of GH and/or IGF-I could influence ghrelin levels. The pathophysiology of ghrelin secretion in acromegaly (specially aftar an oral glucose tolerance test (OGTT) is unclear.<p class="...

ea0016p516 | Obesity | ECE2008

Chronic central infusion of a ghrelin receptor (GHS-R1A) antagonist to rats: impact on ICV ghrelin-induced food intake and altered body composition

Salome N , Gustafsson L , Taube M , Hansson C , Karlsson L , Fehrentz JA , Martinez J , Perrissoud D , Dickson SL

Central treatment with ghrelin increases body weight and fat accumulation. Here we explore the pharmacological effect of a combined central (ICV) infusion of ghrelin (0.3 nmol/day) and a recently developed ghrelin receptor (GHS-R1A) antagonist (JMV2959, 100 nmol/day) on food intake and body composition. The effect of ghrelin infusion for 14 days to increase body weight (20.7±0.9% vs 34.3±3.1%, saline vs ghrelin, P<0.001) was blocked by co-infusion with JMV...

ea0016p636 | Reproduction | ECE2008

Gonadotropin releasing hormone analogue in cyclophosphamide-induced premature gonadal failure prevention

Revert Paula , Moreno Oscar , Lopez-Gomez Juan Miguel , Sivera Francisca , Martinez Sandra , Perdiguero Miguel , Pascual Eliseo , Pico Antonio

Background: Premature ovarian failure (POF) due to cyclophosphamide (Cyc) therapy is well documented in systemic lupus erythematosus (SLE) patients. Studies show that the use of gonadotropin releasing hormone (GnRH) analogues appears to protect women from POF. We present our experience in SLE patients treated with triptorelin.Methods: Observational study of 15 women diagnosed of SLE who have received concomitant treatment with Cyc and GnRH analogues (tri...

ea0016p754 | Thyroid | ECE2008

Interference in assay of thyroid hormones due to auto-antibodies against thyroxine and triiodothyronine: report on two patients with Hashimoto’s thyroiditis

Moreno-Perez Oscar , Serrano Joaquin , Alfayate Rocio , Lopez Maite , Martinez-Fuster Sandra , Arias Nieves , Mauri Monsrrat , Pico Antonio Miguel

Introduction: Characteristically the discordant thyroid function test has been attributed to TSH-producing hypophyseal adenoma, familial dysalbuminemic hyperthyroxinemia and thyroid hormone resistance syndrome. We presented 2 cases with raised peripheral thyroid hormones with detectable TSH due to the presence of auto-antibodies against the peripheral thyroid hormones (PTAAb). <thead valign="...

ea0014p45 | (1) | ECE2007

Progression of diabetic retinopathy in pregestational diabetes mellitus

Guerrero R , Martinez Brocca MA , Pomares MA , Palma S , Gonzalez I , Acosta D , Moreno E , Villamil F

Background: Pregnancy may adversely affect the progression of diabetic retinopathy and can have serious implications for the pregnant women.Aim: To asses the impact of pregnancy on the progression of diabetic retinopathy in women with type 1 and type 2 diabetes mellitus and to identify risk factors for the progression of retinopathy during pregnancy.Methods: 306 diabetic women, 229 (75.4%) with type 1 and 77 (23.9%) with type 2 di...

ea0011p286 | Diabetes, metabolism and cardiovascular | ECE2006

Gene variants at calpain-5 locus are associated with obesity and other features of metabolic syndrome

Saez ME , Martinez-Larrad MT , Ramirez-Lorca R , Gonzalez-Sanchez JL , Zabena C , Gonzalez A , Ruiz A , Serrano-Rios M

Introduction: Genes involved in common complex disorders such as obesity, type 2 diabetes mellitus (T2DM), dyslipidemia or hypertension are not disease specific, since clinically related disorders also share genetic components. These diseases cluster together in the Metabolic Syndrome, a generalized pathology with increased cardiovascular risk in which insulin resistance is considered a key feature. Cysteine protease Calpain-10 (CAPN10) has been associated with T2DM, polycysti...